KC Cheng

Critic
DISC Type : C

Executive Director at Incyte

Wilmington, Delaware, United States

Overview

KC Cheng is the Executive Director of Analytical Science at Incyte, where he leads a team of over 25 scientists. With a PhD from the University of Notre Dame, he specializes in analytical strategy, assay development, and GMP compliance for clinical products. Colleagues describe him as down-to-earth with a good sense of humor under pressure.

Beyond his extensive career in biopharmaceuticals, KC has shown an interest in educational methodologies and language acquisition. This is demonstrated by his engagement with materials on Task-Based Learning and Total Physical Response (TPR) for language teaching, suggesting a passion for effective learning strategies.

He holds a patent for research into "Auto-antigens in inner ear diseases, " highlighting his innovative contributions to scientific research beyond his primary role.

Personality Overview

Precise

ROI Driven

Information Seeker

They choose to analyze logically and value facts to emotions.  It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Analytical Science Strategy
He is responsible for developing and delivering the analytical package to support clinical studies from Phase 1 to BLA filings for regulatory agencies.
Biologics Development
His career focuses on assay development, GMP compliance, lot release, stability programs, and CMC filing for biologics, including antibody and fusion proteins.
Scientific Leadership
He established and built best-in-class analytical labs from the ground up and currently supervises a team of more than 25 scientists across multiple locations.

Media Appearances

KC has no verified media appearances

Work History

2-2023
Executive Director at Incyte
6-2019
Senior Director - Analytical Science at Incyte
8-2016 - 6-2019
Senior Director - Analytical and Formulation Development at VPP/VRC/NIAID/NIH
6-2014 - 7-2016
Senior Director of Analytical Development and QC at Actinium Pharmaceuticals, Inc.
10-2011 - 6-2014
Associate Director, Analytical Development Technology at Bristol-Myers Squibb

Education

2004 - 2006
Executive MBA from Rutgers University–Newark
1984 - 1989
PhD from University of Notre Dame

More Information

Social Presence :

Prographics :

Exp : 24 Location : Wilmington, Delaware, United States Job Level : Senior Designation : Executive Director at Incyte
URL has been copied!

Insights For Selling To KC

During A Call Or A Meeting

DO's

  • Use phrases like ‘expect X% improvement’, ‘data clearly shows’ etc.
  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Don't give superficial answers, they are easily rattled by them
  • Make extra effort to not seem pushy or confrontational

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with KC is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from KC

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will KC move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can KC take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And KC

Personality Compatibility


Other Incyte Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.